» Articles » PMID: 35629064

Do Oral Pathogens Inhabit the Eye and Play a Role in Ocular Diseases?

Overview
Journal J Clin Med
Specialty General Medicine
Date 2022 May 28
PMID 35629064
Authors
Affiliations
Soon will be listed here.
Abstract

Fascinatingly, the immune-privileged healthy eye has a small unique population of microbiota. The human microbiome project led to continuing interest in the ocular microbiome. Typically, ocular microflorae are commensals of low diversity that colonize the external and internal sites of the eye, without instigating any disorders. Ocular commensals modulate immunity and optimally regulate host defense against pathogenic invasion, both on the ocular surface and neuroretina. Yet, any alteration in this symbiotic relationship culminates in the perturbation of ocular homeostasis and shifts the equilibrium toward local or systemic inflammation and, in turn, impaired visual function. A compositional variation in the ocular microbiota is associated with surface disorders such as keratitis, blepharitis, and conjunctivitis. Nevertheless, innovative studies now implicate non-ocular microbial dysbiosis in glaucoma, age-related macular degeneration (AMD), uveitis, and diabetic retinopathy. Accordingly, prompt identification of the extra-ocular etiology and a methodical understanding of the mechanisms of invasion and host-microbial interaction is of paramount importance for preventative and therapeutic interventions for vision-threatening conditions. This review article aims to explore the current literature evidence to better comprehend the role of oral pathogens in the etiopathogenesis of ocular diseases, specifically AMD.

Citing Articles

Could Infectious Agents Play a Role in the Onset of Age-related Macular Degeneration? A Scoping Review.

Larsen P, Dinet V, Delcourt C, Helmer C, Linard M Ophthalmol Sci. 2025; 5(2):100668.

PMID: 39906411 PMC: 11791433. DOI: 10.1016/j.xops.2024.100668.


Fecal microbiota transplantation for glaucoma; a potential emerging treatment strategy.

Ebrahimi R, Farsi Y, Nejadghaderi S Curr Res Microb Sci. 2024; 7:100314.

PMID: 39726974 PMC: 11670420. DOI: 10.1016/j.crmicr.2024.100314.


Microbiome as an endocrine organ and its relationship with eye diseases: Effective factors and new targeted approaches.

Haghshenas L, Banihashemi S, Malekzadegan Y, Catanzaro R, Ahmadi A, Marotta F World J Gastrointest Pathophysiol. 2024; 15(5):96446.

PMID: 39355345 PMC: 11440246. DOI: 10.4291/wjgp.v15.i5.96446.


Molecular Characterization of Bacterial Agents Causing External Ocular Infections Isolates of Patients in a Third Level Hospital.

Duran-Manuel E, Bello-Lopez J, Salinas-Bobadilla A, Vargas-De-Leon C, Nieto-Velazquez N, Moreno-Eutimio M Pathogens. 2023; 12(11).

PMID: 38003759 PMC: 10675722. DOI: 10.3390/pathogens12111294.

References
1.
Huang Y, Wang Z, Ma H, Ji S, Chen Z, Cui Z . Dysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy. Front Cell Infect Microbiol. 2021; 11:646348. PMC: 8017229. DOI: 10.3389/fcimb.2021.646348. View

2.
Arjunan P . Eye on the Enigmatic Link: Dysbiotic Oral Pathogens in Ocular Diseases; The Flip Side. Int Rev Immunol. 2020; 40(6):409-432. DOI: 10.1080/08830185.2020.1845330. View

3.
Baim A, Movahedan A, Farooq A, Skondra D . The microbiome and ophthalmic disease. Exp Biol Med (Maywood). 2018; 244(6):419-429. PMC: 6546998. DOI: 10.1177/1535370218813616. View

4.
Navarcik R, Popov I, Valaskova J, Horkovicova K . SARS-COV-2 PANDEMIC FROM THE OPHTHALMOLOGIST`S PERSPECTIVE. A REVIEW. Cesk Slov Oftalmol. 2022; 78(5):217-332. DOI: 10.31348/2022/1. View

5.
Yucel-Lindberg T, Bage T . Inflammatory mediators in the pathogenesis of periodontitis. Expert Rev Mol Med. 2013; 15:e7. DOI: 10.1017/erm.2013.8. View